https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
233
 
downloads
38
CITE
How to cite this poster:
Greenbaum L, Babu S, Furman R et al. Continued improvements in renal function with sustained eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) resistant to plasma exchange/infusion (PE/PI). F1000Posters 2013, 4:342 (poster)

Continued improvements in renal function with sustained eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) resistant to plasma exchange/infusion (PE/PI)

Larry Greenbaum1, Sunil Babu, Richard Furman, Neil Sheerin, David Cohen, Osama Gaber, Frank Eitner, Yahsou Delmas, Chantal Loirat, Camille L Bedrosian, Christophe Legendre
Published 30 May 2013
Author Affiliations
  • Metrics
  • 233 Views
  • 38 Downloads
Browse by related subjects
Published 30 May 2013

Continued improvements in renal function with sustained eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) resistant to plasma exchange/infusion (PE/PI)

[version 1; not peer reviewed]

Larry Greenbaum1, Sunil Babu, Richard Furman, Neil Sheerin, David Cohen, Osama Gaber, Frank Eitner, Yahsou Delmas, Chantal Loirat, Camille L Bedrosian, Christophe Legendre
Author Affiliations
1 Emory University, USA
Presented at
53rd American Society of Hematology Annual Meeting 2011
Abstract
Competing Interests

Dr Legendre has received compensation for participation in a speakers' bureau for Alexion Pharmaceuticals. Dr Bedrosian is an employee of Alexion Pharmaceuticals. Dr Loirat has been a coordinator of eculizumab trials for, and received honoraria for conferences from, Alexion Pharmaceuticals. Drs Furman, Sheerin, Cohen, Eitner, and Babu have have nothing to disclose.

This study was sponsored by Alexion Pharmaceuticals, Inc.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.